Article
The pathogenesis of hepatocellular carcinoma.
Digestive diseases (Basel, Switzerland) - 1 Jan 2014
Kirstein Martha M, Vogel Arndt
Abstract excerpt
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common and deadly malignancies worldwide. The multikinase inhibitor sorafenib still remains the only approved agent for advanced HCC. In most cases, HCC develops based on advanced liver cirrhosis, whereas the underlying risk factors can be identified in the vast majority of patients. METHODS: Here, we summarise and review the pathomechanisms in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
